Progenika Plans to Commercialize Array-Based Tests for Blood Typing, FH This Year

The commercialization efforts follow a year of activity that saw Progenika open a 12-person US office, establish a sales and marketing team in Madrid, and expand its headquarters in northern Spain.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register quickly here.